PAPER Kelleher RJ, Soiza RL
SEARCH RESULTS
330988 RESULTS
PAPER Prokop S, Miller KR, Heppner FL
Microglia actions in Alzheimer’s disease.
Acta Neuropathol. 2013 Oct;126(4):461-77. PubMed: 24224195APP-C99 (tg13592)
RESEARCH MODELS Modification Details Transgene consisting of the signal plus 99-amino acid carboxyl-terminal sequence (SbC) of human APP under the control of a cytomegalovirus enhancer/β-actin promoter. Neuropathology Although the transgene is expressed in brain and skel
2014 World Cup Final Predictions
FIFARio de Janeiro, Brazil
Rotman Research Institute 2014 Annual Neuroscience Conference
CONFERENCE 2014-03-10 00:00:00-2014-03-11 00:00:00 Omni King Edward Hotel, Toronto, Canada 10 March 2014 to 11 March 2014 Join world-renowned scientists in Toronto at the 24th annual Baycrest Rotman Research Institute conference titled "Memory and the Brain in Health and Disease." March 10-11, 2
Diagnosis
Other Important Notice: The Alzheimer Research Forum does not provide medical advice. The contents are for informational purposes only and are not intended to substitute for professional medical advice, diagnosis or treatment. Always seek advice from a qualifi
Tg-mAPP/RAGE
RESEARCH MODELS Neuropathology Significantly increased activation of microglia and astrocytes compared to mice expressing mutant APP alone. Cognition/Behavior Tg-mAPP/RAGE mice display abnormalities in spatial learning and memory at age three to four months of age, where
PAPER Margineanu DG, Wülfert E
Inhibition by levetiracetam of a non-GABAA receptor-associated epileptiform effect of bicuculline in rat hippocampus.
Br J Pharmacol. 1997 Nov;122(6):1146-50. PubMed: 9401779PAPER Sills GJ, Leach JP, Fraser CM, Forrest G, Patsalos PN, Brodie MJ
Neurochemical studies with the novel anticonvulsant levetiracetam in mouse brain.
Eur J Pharmacol. 1997 Apr 23;325(1):35-40. PubMed: 9151936Q&A with Richard Bozanich
Other Questions by Gabrielle Strobel Richard Bozanich, 50, has early onset dementia, Probable Alzheimer's Type. During his career, Bozanich was a journalist who wrote and/or edited for the Harvard Business School, the Los Angeles Times, the Dallas Morning
Interview: One Man's Forward Approach
Other Thomas Greene's mother developed AD in her mid-thirties. Thomas decided to end uncertainty about his own genetic status and took a predictive test when he was 31. When it came back positive for an AD mutation, he grabbed the bull by its horns as best
Interview with Jennifer Williamson
Other By Gabrielle Strobel Jennifer Williamson is a genetic counselor at the Taub Institute for Research on Alzheimer's Disease and the Aging Brain and the Gertrude H. Sergievsky Center at Columbia University, New York. She sees families with neurogenetic
Tg-mAPP/DN-RAGE
RESEARCH MODELS Neuropathology Bigenic mice expressing dominant-negative RAGE as well as mutant APP displayed diminished neuropathology compared with mice expressing mutant APP alone, including the area occupied by acetylcholinesterase-positive fibers in the subiculum at
NPR Audio Interviews with Thomas Debaggio
Other When he was 55, herb farmer Tom DeBaggio, called the "Best Rosemaryologist in the country," began to notice problems with his memory. Working the checkout register of his family business, he could not name plants he'd been growing for decad
Where to Turn for Research: Human Studies of eFAD
Other By Gabrielle Strobel Editor's note: For definitions of early onset Alzheimer disease (EOAD) and early onset familial Alzheimer disease (eFAD), please see our essay, What Is Early Onset Familial Alzheimer Disease (eFAD)? Families with eFAD who are wi
Current Filters
No filters selected